Джозеф Меркола - Кето-навигатор

79. Vancassel S, Durand G, Barthelemy C, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids . 2001 Jul; 65 (1): 1–7.

80. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

81. Там же.

82. Amminger GP, Berger GE, Schafer MR, et al. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry . 2007 Feb 15; 61 (4): 551–553.

83. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

84. Fontani G, Corradeschi F, Felici A, et al. Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest . 2005 Nov; 35 (11): 691–699.

85. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

86. Zanarini MC, Frankenburg FR. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry . 2003 Jan; 160 (1): 167–169.

87. De Vriese SR, Christophe AB, Maes M. In humans, the seasonal variation in poly-unsaturated fatty acids is related to the seasonal variation in violent suicide and serotonergic markers of violent suicide. Prostaglandins Leukot Essent Fatty Acids . 2004 Jul; 71 (1): 13–18.

88. Lewis MD, Hibbeln JR, Johnson JE, et al. Suicide deaths of active-duty US military and omega-3 fatty-acid status: a case-control comparison. J Clin Psychiatry . 2011 Dec; 72 (1): 1585–1590.

89. Huan M, Hamazaki K, Sun Y, et al. Suicide attempt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry . 2004 Oct 1; 56 (7): 490–496.

90. Hallahan B, Hibbeln JR, Davis JM, et al. Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry . 2007 Feb; 190: 118–122.

91. Green P, Hermesh H, Monselise A, et al. Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol . 2006 Feb; 16 (2): 107–113.

92. Chiu CC, Huang SY, Su KP, et al. Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol . 2003 Mar; 13 (2): 99–103.

93. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

94. Connor WE, Connor SL. The importance of fish and docosahexaenoic acid in Alzheimer disease. Am J Clin Nutr . 2007 Apr; 85 (4): 929–930.

95. Andlin-Sobocki P, Jonsson B, Wittchen HU, et al. Cost of disorders of the brain in Europe. Eur J Neurol . 2005 Jun; 12 Suppl 1: 1–27.

96. Olesen J, Gustavsson A, Svensson M, et al. The economic cost of brain disorders in Europe. Eur J Neurol . 2012 Jan; 19 (1): 155–162.

97. Prasad MR, Lovell MA, Yatin M, et al. Regional membrane phospholipid alterations in Alzheimer’s disease. Neurochem Res . 1998 Jan; 23 (1): 81–88.

98. Kidd PM. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev . 2007 Sep; 12 (3): 207–227.

99. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnology J . 2006 Apr; 1 (4): 420–439.

100. Moyad MA. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II. Urol Oncol . 2005 Jan-Feb; 23 (1): 36–48.

101. Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol . 1997 Nov; 42 (5): 776–782.

102. Barberger-Gateau P, Letenneur L, Deschamps V, et al. Fish, meat, and risk of dementia: cohort study. BMJ. 2002 Oct 26; 325 (7370): 932–933.

103. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol . 2003 Jul; 60 (7): 940–946.

104. Freemantle E, Vandal M, Tremblay-Mercier J, et al. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids . 2006 Sep; 75 (3): 213–220.

105. Там же.

106. Там же.

107. Там же.

108. Там же.

109. Tully AM, Roche HM, Doyle R, et al. Low serum cholesteryl esterdocosahexaenoic acid levels in Alzheimer’s disease: a case-control study. Br J Nutr . 2003 Apr; 89 (4): 483–489.

110. Conquer JA, Tierney MC, Zecevic J, et al. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids. 2000 Dec; 35 (12): 1305–1312.

111. Huang TL. Omega-3 fatty acids, cognitive decline, and Alzheimer’s disease: a critical review and evaluation of the literature. J Alzheimers Dis . 2010; 21 (3): 673–690.

112. Whalley LJ, Deary IJ, Starr JM, et al. n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational followup study in late adulthood. Am J Clin Nutr . 2008 Feb; 87 (2): 449–454.

113. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging . 2012 Jul; 33 (7): 1482.e17–29.

114. Freemantle E, Vandal M, Tremblay-Mercier J, et al. Omega-3 fatty acids, energy substrates, and brain function during aging. Prostaglandins Leukot Essent Fatty Acids . 2006 Sep; 75 (3): 213–220.

115. Conquer JA, Tierney MC, Zecevic J, et al. Fatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairment. Lipids. 2000 Dec; 35 (12): 1305–1312.

116. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol . 2006 Nov; 63 (11): 1545–1550.

117. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol . 2006 Oct; 63 (1): 1402–1408.

118. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging . 2012 Jul; 33 (7): 1482.e17–29.

119. Shinto L, Quinn J, Montine T, et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s disease. J Alzheimers Dis . 2014; 38 (1): 111–120.

120. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging . 2012 Jul; 33 (7): 1482.e17–29.

121. Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol . 1997 Nov; 42 (5): 776–782.

122. Barberger-Gateau P, Letenneur L, Deschamps V, et al. Fish, meat, and risk of dementia: cohort study. BMJ. 2002 Oct 26; 325 (7370): 932–933.

123. Richardson AJ, Puri BK. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Prog Neuropsychopharmacol Biol Psychiatry . 2002 Feb; 26 (2): 233–239.

124. Vancassel S, Durand G, Barthelemy C, et al. Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids . 2001 Jul; 65 (1): 1–7.

125. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids . 2002 Nov; 67 (5): 311–318.

126. Mamalakis G, Kalogeropoulos N, Andrikopoulos N, et al. Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr . 2006 Jul; 60 (7): 882–888.

127. Zanarini MC, Frankenburg FR. Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry . 2003 Jan; 160 (1): 167–169.

128. Assies J, Lieverse R, Vreken P, et al. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry . 2001 Mar 15; 49 (6): 510–522.

129. Hamazaki T, Sawazaki S, Itomura M, et al. Effect of docosahexaenoic acid on hostility. World Rev Nutr Diet . 2001; 88: 47–52.

130. Mamalakis G, Kafatos A, Tornaritis M, et al. Anxiety and adipose essential fatty acid precursors for prostaglandin E1 and E2. J Am Coll Nutr . 1998 Jun; 17 (3): 239–243.

131. Shakeri J, Khanegi M, Golshani S, et al. Effects of omega-3 supplement in the treatment of patients with bipolar I disorder. Int J Prev Med . 2016 May 19; 7: 77.

132. Vesco AT, Lehmann J, Gracious BL, et al. Omega-3 supplementation for psychotic mania and comorbid anxiety in children. J Child Adolesc Psychopharmacol . 2015 Sep 1; 25 (7): 526–34.

133. Cott J, Hibbeln JR. Lack of seasonal mood change in Icelanders. Am J Psychiatry . 2001 Feb; 158 (2): 328.

134. Wong-Ekkabut J, Xu Z, Triampo W, et al. Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys J .2007 Dec 15; 93 (12): 4225–4236.

135. Spiteller G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic Biol Med . 2006 Aug 1; 41(3): 362–387.

136. Там же.

137. Там же.

138. Moran JH, Mon T, Hendrickson TL, et al. Defining mechanisms of toxicity for linoleic acid monoepoxides and diols in Sf-21 cells. Chem Res Toxicol . 2001 Apr; 14 (4): 431–437.

139. Montine TJ, Amarnath V, Martin ME, et al. E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol . 1996 Jan; 148 (1): 89–93.

140. Best KP, Gold M, Kennedy D, et al. Omega-3 long-chain PUFA intake during pregnancy and allergic disease outcomes in the offspring: a systematic review and meta-analysis of observational studies and randomized controlled trials. Am J Clin Nutr . 2016 Jan; 103 (1): 128–143.

141. Там же.

142. Там же.

143. Maslova E, Strom M, Oken E, et al. Fish intake during pregnancy and the risk of child asthma and allergic rhinitis – longitudinal evidence from the Danish National Birth Cohort. Br J Nutr . 2013 Oct; 110 (7): 1313–1325.

144. Nwaru BI, Erkkola M, Lumia M, et al. Maternal intake of fatty acids during pregnancy and allergies in the offspring. Br J Nutr . 2012 Aug; 108 (4): 720–732.

145. Jedrychowski W, Perera F, Maugeri U, et al. Effects of prenatal and perinatal exposure to fine air pollutants and maternal fish consumption on the occurrence of infantile eczema. Int Arch Allergy Immunol . 2011; 155 (3): 275–281.